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Human genetics must acknowledge many sources, but the earliest and perhaps
most symbolic are Archibald Garrod and Francis Galton. I would like to begin
with the contributions of these two men and what they stood for, because a look
at human genetics in the context of the clinician suggests that it is strongly gar-
rodian, but only weakly galtonian. On the other hand, there are strong pressures
advancing the latter's viewpoint which may broaden the dimensions of the clini-
cian's practice and which invite him to assume some responsibility for decisions
about social issues arising out of the genetic causes of human differences.
GARROD AND GALTON
Garrod (1857-1936) was first of all a clinician, and an outstanding one. He
was unique in his time for his knowledge of biology and biochemistry and for doing
laboratory investigations. Everyone knows that he was the first to conceive the
relationship between genes and enzymes which accounted for the variations he
called inborn errors of metabolism. It is little known, however, that he extended
his original insight to predict the molecular and genetical basis of variations of
all functions under biochemical control; that is, all life functions, including physical
appearance, responses to drugs, susceptibilities to disease, and even behavior. He
thus outlined what later discoveries have attested; that each human being can be
distinguished from all others by virtue of the possession of a unique set of protein
molecules, and that the directions for this singularity are encoded in the genes.
Garrod's view was that of a good clinician, inward looking, seeking the pathogene-
sis of nonadaptive differences in individual persons with a view to setting them
right. In his later years he was especially interested in the genetic origin of suscepti-
bility to disease or diatheses, suggesting that these, too, must have a molecular
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basis, and that the key to the solution of these diseases lay in understanding the
interaction of genes and environment. Garrod was very much a medical man who
saw things as a physician does.
Francis Galton (1822-1911), also an Englishman, had a different outlook. He
was one of those extraordinary Victorian gentlemen whose financial independence
allowed him to live a largely intellectual life. He was a first cousin of Charles Dar-
win and was strongly influenced by him. Originally a geographer and explorer,
he turned in time to study the qualities and causes of individuality in the human
species. His accomplishments were many. He was the first to appreciate the dis-
tinguishing qualities of finger prints; the first to use twins to partition the effects
of heredity and experience; and the first to ascribe to heredity many intellectual,
sensory, and behavioral properties. Measurement was his obsession. Observations
were classified into quartiles, deciles, and the like, and the necessity to see the
quantitative relationships of measurements between individuals caused him to in-
vent the correlation and regression coefficients. In the main, he studied the inheri-
tance of characters which are continuously distributed and which do not segregate,
and he was interested in establishing the degree to which such traits are heritable.
That is, unlike Garrod, whose object was to understand the molecular basis of
heritable variation, Galton wished to know the average degree to which a character
is inherited by the whole species. This preoccupation with species inheritance led
him to suggest that humankind might be improved by differential reproduction and
to invent the word eugenics to embody the idea. Thus, his view of heredity differs
from that of Garrod in looking outward to consider the extent of variation in whole
populations and to see the individual in his position in the distribution. It is not
surprising that Galton's concepts engendered population genetics.
MODERN MEDICAL GENETICS
It might be supposed that with so favorable a start human or medical genetics
would have flourished from the beginning, but it did not and probably could not,
having as it did to await the development of the theory of the gene, of cytogenetics,
and of mechanisms of gene action. Even the discovery and elucidation of inborn
errors could not proceed until the invention of appropriate biochemical techniques,
and in any case babies with severe metabolic errors must have died early of infec-
tions, and multiple deaths in infancy in families must have been a commonplace
event not easily assignable to any genetic cause. So genetics developed outside the
medical school and hospital in botanical and zoological laboratories, and the earli-
est devotees of human genetics were mainly scientists to whom the biology of man
was not a primary interest. Genetics must be, therefore, the only scientific discipline
to be imposed upon medical education and practice from without. Biochemistry,
physiology, microbiology, and even molecular biology, have been for the most part
lodged in schools of medicine, and new developments have always been passed
on to current crops of students. Not so with genetics, which is a recent arrival.
Figure 1 shows, for example, that it was not until the early 60's that the number
of papers listed in the Index Medicus under such headings as human genetics, chro-
mosomes, and human heredity surpassed the number devoted to hernias. This surge
in research effort was the result of the discovery of a way to look at human chro-
mosomes, of biochemical techniques to assay enzymes and other proteins, and to
study their physical properties, and of the means to separate and measure metabo-
lites in body fluids. These biochemical feats must delight Sir Archibald's shade.
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Figure 2 shows the exponential rate of discovery of enzyme deficiencies which
qualify as inborn errors in the garrodian sense. There appears to be no letup, and
theory suggests that, barring a meanness of spirit at the Office of Management
and Budget, there should be none for a long time. Further, for many of the loci
specifying the mutants which cause those inborn errors more than one variant allele
has been discovered (1). Some of these multiple allelic systems are surprisingly
large; the hemoglobins number over 100, the G6PD's over 80, and several
others number in excess of 10, and some of these have been shown to account
for the variability in severity and symptoms of disease. The discovery of the cause
of a disease usually suggests what to do about it and clinicians have responded
to this proliferation of genetic disorders by designing treatments which alter the
environment in such a way as to nullify the adverse effects of the mutant genes;
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FIG. 1. Research in human genetics did not exceed that devoted to hernias before the early
1960's. Human heredity, 0; hernia, X.
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FIG. 2. Discovery of new inborn errors of metabolism is proceeding exponentially.
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TABLE 1
A GREAT DEAL MORE IS KNOWN TODAY ABOUT INBORN ERRORS THAN WAS
KNOWN TO SIR ARCHIBALD GARROD
Garrod's 3rd Edition of
inborn errors "Metabolic Basis of
of metabolism Inherited Disease"
Date of publication 1909 1972
Weight 300 g 2400 g
Contributors 1 93
Chapters 6 74
References 248 14,690
Ref/chapt 41.3 198.5
Pages 168 1778
Surface area (sq in) 9300 137,795
Words/page 235 900-1000
Index pages 11 41
Index items 600 7075
Cost $2.50 $45.00
Cost/g of book 0.90s 1.87¢
treatments varying all the way from adding to or subtracting something from the
diet to transplantation.
I have emphasized the metabolic side of human genetics because of its obvious
connection with Garrod, but as everyone knows, there has been an equal expansion
of knowledge of chromosomal abnormality and of other aspects of clinical genetics.
A glance at the editions of "The Metabolic Basis of Inherited Diseases," as well
as at McKusick's catalogues of mendelian traits, tells the story (2, 3). Perhaps
it is even better revealed by a comparison, shown in Table 1, of the third edition
of "The Metabolic Basis of Inherited Diseases" and Garrod's "Inborn Errors of
Metabolism" (4). All of this is in the traditional medical vein. The diseases may
be rare, their names unpronounceable, and the pathways and metabolites impossi-
ble to memorize, but none of this strains in any way the conventional affinity be-
tween the doctor and his patient. It is sufficient for the clinician to think of the
mutant gene or the abnormal chromosome as a causative agent, conceptually simi-
lar to a microorganism whose ill effects must be neutralized when possible by en-
vironmental manipulation. If definitive treatment is not possible, physicians are
accustomed to providing symptomatic relief as well as other forms of support.
POPULATION GENETICS
It would be a mistake to suppose that human genetics is concerned wholly, or
even mainly, with the detection and description of new genetic disorders and with
their biochemical elucidation and treatment. The fact that chromosomes segregate
and genes assort themselves independently allows us to predict their distribution
in families and in populations, and geneticists have worked out mathematical state-
ments of those distributions in various mating systems and under environmental
conditions favorable or unfavorable for their spread. The theories of population
genetics were worked out in the 1920's and 30's, but they have had to wait until
now to be tested because of a lack of traits to provide the empirical data to support
or contradict them. This deficit is being made up by the discovery of variant protein
molecules of all kinds, whose distribution in families attests to their genetic origins.
Some of these are the defective molecules which account for the inborn errors,
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while others, although structurally unique, cause no apparent physiological differ-
ence. Some of the genes specifying these molecules, calledpolymorphic genes, are
common in the population, reaching frequencies of more than 1%, while others
are restricted to particular families. Probably a majority of the gene loci show ge-
netic polymorphism, enough at least so that about 20% of the loci of each human
being are heterozygous for alleles determining alternative forms of the correspond-
ing proteins (5). The search for these variants goes forward so that what is being
begun is a tabulation of the genetic quality of man.
The result of all this is the recognition that the human species is as variable
as any other and more variable than had been suspected, and questions are being
asked whether genes with frequencies in the population of 1 or 2% or more are
so common because they are adaptively favorable, or because although selectively
neutral they have accumulated at random (6).
The relationship of this aspect of genetics to medicine in the distant future is
easy to project. One might extract from a culture of cells derived from an early
fetus a catalogue of gene products which would give strong indications of future
developmental directions, allowing the physician to map the future, if any, for that
fetus. This possibility is not open to us now, may never be, and as outlined may
be morally undesirable. In any case, we need not worry about the remote future,
the question for now is whether population genetics has something for clinical
medicine of the present and near future.
I think it is reasonable to say that clinicians are generally ignorant of population
genetics and do not see its relationship to their patients. One reason for this is
that many investigations have gone on outside the purview of clinical medicine.
Many of the investigators are nonmedical and even those with medical training
are seldom working in clinical departments. Nor is a great deal of the work pub-
lished in such a way as to attract the attention of clinicians, least of all those in
practice. A recently published and comprehensive book entitled "The Genetics of
Human Populations" lists over 700 references (6). Of these, only 28, or 4%, were
to journals which might be read or glanced through by practicing physicians. A
further 10% were to journals such as Science, Nature, The Proceedings of the
National Academy of Sciences, Proceedings of the Royal Society, and Scientific
American, journals which clinical investigators would look at, but would read selec-
tively. About 18% of the references were to books, of which only a few would
even be seen by clinicians or clinical investigators let alone be read, and of the
rest, most were to genetics journals and transactions of congresses and symposia
which would be likely to be scanned only by the handful of clinicians interested
especially in genetics.
A second reason has to do with the nature of physicians, the exigencies of prac-
tice as they see them, and their view of their role in medicine. The doctor is con-
cerned largely with the immediate complaints of patients; deals with the diseases
of individual persons, not of society or of any other statistical unit; lacks much
interest in the theoreticaJ or in that which cannot be put to immediate use; and
always requires strong empirical evidence to cause him to move.
Population genetics is still theoretical, strongly mathematical, and still insuffi-
ciently buttressed by empirical data. Its concern is primarily biological but it is
also strongly social and evolutionary and has lately engendered public musings
about the uses of genetics for the improvement of the human race. In short, it
is a galtonian view and it has led to new looks at eugenics, mainly by molecular
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biologists and geneticists. It is not surprising that it should be geneticists who dis-
cuss eugenics. Their view of human life is unlike that of the physician; their think-
ing is more abstract, theoretical, and experimental. Their view of man is evolution-
ary. They see him in relation to other forms of life, as a species with a past and
an uncertain future. They have recently witnessed, or participated in, the discovery
of fundamental truths about genetics andlife, and they suggest that the newprinci-
ples which apply generally to all living things ought to be used to improve man's
welfare and to give constructive direction to his evolution.
POPULATION GENETICS AND CLINICAL MEDICINE
We have seen how readily the clinician has absorbed the lessons of Garrod;
the imposition of a galtonian stamp on clinical medicine is another matter.
Genetic counseling, antenatal diagnosis after amniocentesis, and population
screening for genetic disease are all going on in one form or another and represent
the present interface between clinical medicine and population genetics. Each of
these can be seen in the narrow context of individual patient care, but each has
also wide social implications which have not been systematically studied or even
faced, and which tend to enlarge the doctor's responsibilities. These are mainly
measures of negative eugenics, and beyond these are measures of positive eugenics
for which neither the people nor the medical profession are ready, but which sug-
gest the capabilities science will offer and which can be devoted to human welfare
if we are ever wise enough and judicious enough to decide whether to use them
or to reject them.
Genetic Counseling
Genetic counseling has two purposes. One of these is to give interested persons
a discussion of the genetic aspects of their problem including odds for or against
particular reproductive outcomes. The second is to provide such support as may
be derived from advice about contraception, adoption, and the use of social agen-
cies, as well as to try to resolve the emotional turmoil engendered by the burden
of genetic diseases and the damage to self-esteem which may result from learning
that one is the possessor of genes capable of bringing harm to one's children. Much
of this is old stuff for physicians, who give supportive help every day, but the recita-
tion of odds is still approached with diffidence by some doctors, and, if the genetics
of the condition is obscure, many prefer to send the patient to a genetics clinic.
Even this wariness about genetics is a matter which education might solve, since
it is in the conventional doctor-patient context; but what of the patient's relatives
whose risks can be calculated with precision and who do not happen to be in the
doctor's practice? Whose duty, if anyone's, is it to tell the sisters of a woman who
has a hemophilic child and who has been shown to be a heterozygote, that they
are at risk? And what about the mother's female first cousins, who have a one-
eighth chance of having the mutant too? Some physicians assume some responsibil-
ity, others don't; some parents warn their relatives, others don't, but surely there
is some social obligation here to all the members of the family. Some geneticists
have proposed to deal with this question by means of computerized registries (7).
Each new family is entered in the registry, including all of the relatives. If desirable,
these data can be linked with such other information already public property as
birth and death records, census material, and the like. In this way, people at risk
can be discovered who are utterly unaware of their jeopardy. Should they be told,
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and who should do the telling, and who shall give them appropriate counseling,
and to what doctor will they be sent in the end? Such methods need to be studied
and may or may not become the rule, but whatever mode of dealing with families
is settled upon, some kind of violence will have been done to the conventional
doctor-patient relationship.
A review of the literature of genetic counseling reveals differences in the goals
of counseling (8). Most counselors see this service in the orthodox light of provid-
ing a patient or parent with the wherewithal to make intelligent choices about fur-
ther reproduction, but some see it as a means of reducing the number of defective
persons in the population; to these latter it is an eugenic measure. For the former,
success must be measured by the patient's or parent's own statement that knowing
the risks and the potential burden they made a choice-either way, while to the
latter success is inversely proportional to the number of children born after counsel-
ing. No one knows how many practicing doctors are now doing genetic counseling,
or among those who do, how many preserve neutrality with regard to the coun-
selee's reproductive decisions, or how many are directive. Nor do we know the
outcomes of counseling by all counselors, so we cannot judge to what degree coun-
seling may be reducing the numbers of persons with genetic disease, or even if
it is, whether it is the risks or the burden which is decisive in the choice not to
reproduce (9).
Amniocentesis and Antenatal Diagnosis
Physicians are generally more comfortable in telling patients of something they
can do rather than warning against the hazards of action, so urging antenatal testing
and abortion of affected fetuses is very much in the traditional medical vein. On
the other hand, selective abortion is at least a novel idea to doctors whose primary
aim is to protect and support life. More foreign to ordinary practice is the idea
of pressing this possibility on people who have not asked for it. Even more out
of the usual is the request for a baby of a given sex; obviously a normal fetus
of the unwanted sex is to be aborted. Should amniocentesis become a routine pro-
cedure during every pregnancy, it could become an instrument of population con-
trol, or at least for the control of sex determination. Etzioni has reviewed the pos-
sible consequences of control of sex determination as an example of the impact
on the whole society of the use by physicians of a medical technique designed to
fulfill the requirements of single patients (10). The results are not particularly
alarming, but have widespread social effects not envisioned in the rationales for
sex choice each time it is carried out.
Antenatal diagnosis and selective abortion can be used to reduce significantly
the incidence of genetic diseases only if the people and matings at risk in the popu-
lation can be identified; that is, families who could have, but have not yet had,
affected babies must be included (11). If this were to be done, and it should be
stated that it is not yet certain for how many diseases it ought to be done, it would
require all physicians, but perhaps particularly general practitioners, obstetricians,
and pediatricians, to ensure that their patients were screened for many genes, a
list of which is likely to increase year by year. It should be noted that this must
be a cooperative venture for the doctors, since, as with all public health measures,
the success of this one depends upon affecting a maximum proportion of the popu-
lation. Incidentally, any dysgenic effects of these tactics are likely to be minimal
(11).
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Mass Screening
Mass screening is a distinct departure from conventional episodic medical care
and very much of a piece with the new ideas of community medicine. But the
scope of screening for genetic characters can be broader than that envisioned in
any current medical care program. That is, there are several objectives, running
all the way from the discovery of persons with treatable diseases to finding persons
who are not themselves at risk for anything but who carry genes which, given an
appropriate mating, could put an unborn offspring at risk for an untreatable condi-
tion. It is doubtful that practitioners devote much thought to screening for genetic
disease, since state and city health departments usually administer the screening
for PKU and other inborn errors. Mass screening for Tay-Sachs disease and sickle
cell disease and trait, however, have had much recent exposure in the public and
medical media drawing attention to screening, so that there is some chance that
such screening for a diverse list of conditions will go forward, involving practition-
ers, whether they think about it or not. As this list of genetic susceptibilities in-
creases, as undoubtedly it will, some mechanisms will be required to counsel the
large numbers of possessors of such genes and to help them to live with them.
This could be done by health departments in some way, but would be better han-
dled by clinicians accustomed to giving medical care. Perhaps group sessions or
family meetings would be the way. Certainly ancillary medical personnel experi-
enced in counseling and in home visiting have been proved useful (12). In addi-
tion, mechanisms for the education of the public and of persons shown to be car-
riers or otherwise affected will be required. The conditions now being screened
do not in the aggregate affect a very large proportion of the population, but if
it becomes possible and is judged desirable to screen for genetic susceptibility for
such frequent disorders as diabetes, psychoses, hypertension, some forms of cancer,
and the like, then a practitioner lacking some appropriate mechanism to deal with
the numbers would be hard put to keep up with it all.
Positive Eugenics
Although positive eugenic measures (summarized in Table 2) are even less con-
genial to medical practice, they should be mentioned here both because they have
been the subject of articles in the public press and because their proponents are,
for the most part, nonmedical scientists with strong beliefs in social improvement.
But they seem to me to have little practical significance for the clinician of the
moment. Everyone agrees that direct manipulation of genes, however desirable,
will not be done soon. The various forms of reproductive manipulation are perhaps
more feasible, but raise more immediate questions of ethics and social acceptability,
but even in the unlikely event that they are judged acceptable, they would have
TABLE 2
MEASURES OF POSITIVE EUGENICS
Addition, subtraction, repair of genes in germ cell lines
Reproductive manipulation, in vitro fertilization
Cloning
Parthenogenesis
Germinal selection
Selective mating
Artificial insemination
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little effect on the genetic quality of the human race. As for germinal selection,
or the means to improve human quality by selective reproduction of persons with
desirable genes, this too must await a day when we have some idea of which genes
are desirable, which combinations are desirable, and what environments are re-
quired to bring out their beneficial effects. It might be possible also in that distant
future to persuade people to mate for genetic rather than emotional reasons, but
for the moment, even leaving aside our inability to select the "best" mating, germi-
nal selection surely must be at the bottom of the list of reasons, not so say impulses,
which cause people to mate.
There is a sizeable literature on these eugenic measures consisting of papers,
transactions of symposia, and a few books. Table 3 lists the symposia by their
rather resounding, even apocalyptic titles, and shows that the bulk of the partici-
pants and authors have been nonmedical persons; indeed, in only one session have
the medical out-numbered the nonmedical (13-22). In addition, a review of the
literature revealed that of 45 authors of 53 papers written on these subjects be-
tween 1959 and 1972, only 18 of the authors, or about one third, were medical
(23-75). Some of the nonmedical authors and many of the nonmedical participants
in the symposia were clergymen, philosophers, or lawyers, and that is as it should
be; the future of man is too important to be left to physicians, but the heavy non-
medical preponderance is due to the geneticists, who in the galtonian manner hope
to put our knowledge of genetics to work in the interest of man, or to make sure
that such knowledge is not misused. These exercises, then, were a means of bring-
ing eugenic possibilities to the attention of the scientific community and to the
public with the idea of starting some debate. Medical authors and participants in
the symposia, on the other hand, true to their traditions do not see the immediate
applications, especially of the more outre of these suggestions, and in any case
are wary of schemes for the improvement of man and so tended to draw the
discussion around to the uses and misuses of antenatal diagnosis, screening, and
counseling.
The effects of this debate on medical practice, if any, are not clear and may
not be clear for a long time, but whatever else it does, it should help to direct
the medical view to genetic issues of wide social concern not now seen to be in
TABLE 3
SYMPOSIA ON EUGENICS AND HUMAN EVOLUTION
Participants
Title of symposium Notimedical Medical Total Reference
Evolution and Man's Progress 9 0 9 13
The Control of Human Heredity and
Evolution 7 1 8 14
Biology and the Future of Man 7 1 8 15
The Future of Man 19 7 26 16
Genetics and the Future of Man 7 0 7 17
Who Shall Live 6 0 6 18
Changing Mores of Biomedical Research 7 3 10 19
Genetic Engineering 6 2 8 20
The New Genetics and the Future of Man 9 3 12 21
Ethical Issues in Human Genetics 16 19 35 22
Total 94 36 129
(Percent) (72.9) (27.1) (100.0)
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its province. A good example is the mutagenic effects of a variety of agents in
common use. Edwards has pointed out that those technological advances which
have made life generally safe and more comfortable paradoxically have added to
the hazards of intrauterine life by exposing the embryo to drugs, chemicals, pollu-
tants, radiation, and the like, all of which can be both teratogenic and mutagenic
(76). The mutagenic properties of these agents have received little or no attention
from physicians, but geneticists have been active in working out systems for testing
mutagenicity and pressing for recognition of the problem by appropriate govern-
ment agencies (77, 78).
THE FUTURE
If, in fact, clinicians are insufficiently galtonian in knowledge and uses of ge-
netics, what should be done about it? What is needed is first, some conceptual
treatment of population genetics which puts it into the context of medical practice,
a frame of reference congenial to a physician whose time and energies are taken
up with patient care; and secondly, places to center research and teaching which
will have access to patients, families, and populations.
A Context for Teaching
As for the conceptual approach, what is required is to show that knowledge
of the genetic structure of the population is conjunctive to clinical medicine, that
mating systems, the distributions of genes in families and in larger groups, their
frequencies, the causes of their equilibria, and their ebb and flow are all of im-
portance to the clinician. We must translate the selective value of genes into clinical
terms and try to discover the significance of the polymorphisms. We must impress
the clinician that each patient is shaped by the concatenation of genes which are
his by random chance and that all human variations, including onset, extent, se-
verity, and duration of disease are likely significantly to be influenced by those
genes.
It might be argued that there are insufficient empirical data to link genetics to
medicine except in the sense of cause of disease; a deficiency which will leave phy-
sicians unimpressed since they are usually interested only in that which is of prac-
tical use in coping with their patients. But screening for inborn errors in this country
and abroad has established frequencies for a number of diseases, and for the rele-
vant genes and their carrier states, and other studies give frequency figures for
several chromosome abnormalities as well. In addition, there must be 50-60 loci
for which there are alleles with frequencies of over 1%, and while the selective
qualities and functional implications of few of these common genes are known,
some examples suggesting what is in store are coming to light (5, 79).
One such example is the locus specifying the a1 trypsin inhibitor protein. In
all there are 19 known alleles, of which four, including the Z and s alleles, have
been found in Scandinavian and U.S. populations in frequencies in excess of 1%
(80-83). The Z allele in homozygotes causes a deficiency of the inhibitor which
is associated with severe emphysema of early onset or with cirrhosis, both of in-
fancy and adult life. In addition, there are suggestions that other genotypes, es-
pecially Zs, are associated with the emphysema of smoking, although the evidence
on this is conflicting. But such uncertainty, given the small numbers of persons
studied, is precisely what one should expect. To begin with, there are 190 possible
genotypes, and even if it were possible to grade these with regard to tendency to
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emphysema, given exactly the same environment, actual outcomes in each separate
individual must depend upon exposure to pollutants and infections, as well as the
number and quality of cigarettes and the duration of the habit. Nor can we ignore
the modifying effects of other genes, each of which may be representative of some
equally elaborate allelic system. For example, since the cause of the emphysema
is thought to consist of attack on elastic fibers by uninhibited proteases, variability
in onset and extent of disease could be due to functional differences of alleles for
both proteases and elastins. In fact, the condition is simpler than this because only
three or four of the alleles are as frequent as 1 or 2%, so perhaps only 10 geno-
types are of much numerical importance. Still, the 19 alleles currently known have
been discovered after study of only a few thousand persons and the history of
the hemoglobin and G6PD loci suggests that many more alleles, some of which
may be as nonadaptive as Z, remain to be discovered.
Other examples exist. Association of the H-La antigens with many diseases, usu-
ally malignant or of autoimmune origin, have been detected (84, 85). These anti-
gens are the products of a complex locus with many alleles, most of which are
very frequent in the population. Diseases such as Hodgkin's and other lymphomas,
psoriasis, ankylosing spondylitis, glomerulonephritis, lupus erythematosus, and
others have been found to show variable, but some very strong, associations to
certain antigens and genes. The reasons for these relationships remain a mystery,
but whatever they are, they are clues to the susceptibility of some persons and
resistance of others, genetic markers of a sort. Another interesting example is given
by the acetyl transferase locus. Two very common alleles specify enzyme molecules
which differ in the rate at which many metabolites are acetylated. A recent paper
reporting observations on the efficacy of phenelzine as a treatment for neurotic
depression revealed that the drug was successful if the patient was a fast acetylator,
but failed to work nearly as well for the slow acetylators (86).
Recognition of the influence of genes controlling variations in blood lipid levels
on the development of atherosclerosis and coronary artery disease is just beginning
(87, 88). Genetic causes of variations in such other risk factors as obesity, hyper-
tension, diabetes, and physiological responses to smoking are not known, but it
is an entirely safe bet that they exist and that in time a person's status with regard
to the probability of having a heart attack in some part of life will be established
by the possession of particular alleles at several, or more likely many, loci.
I referred previously to the polymorphic loci whose constellations contain two
or more common alleles. The metabolic effects of most of these genes is unknown,
and the population geneticists cannot conclude on theoretical grounds whether they
have accumulated in the population for selective reasons or by random drift. Intu-
ition would suggest both, and that in any case they are the source of much human
variation. The examples just cited suggest as much and hint that the polymorphic
genes play some part in common disorders whose origins are thought to be multi-
factorial; that is, due to the action of several genes in particular environments.
Since these diseases are common, as opposed to the rare inborn errors of metabo-
lism, the genes which predispose to them must be common, and what other reser-
voir exists than the polymorphic loci (89)?
Places for Research and Teaching
Impressive progress in teaching genetics in medical schools has been made. Of
96 schools whose 1972 catalogues were available to me, 47, or about 52%, list
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TABLE 4
DEPARTMENTS OF GENETICS AND DERMATOLOGY IN AMERICAN MEDICAL SCHOOLS
Department Division Neither Total
No. % No. % No. % No. %
Genetics 19 17.1 28 25.2 64 57.7 111 100.0
Dermatologya 35 33.1 41 38.2 30 28.3 106 100.0
a Five two-year schools had no clinical departments.
TABLE 5
NATIONAL INSTITUTES OF HEALTH RESEARCH SUPPORT FOR AMERICAN MEDICAL SCHOOLS DIVIDED
ACCORDING TO WHETHER THEY HAVE DEPARTMENTS AND DIVISIONS OF GENETICS
Number of Percent of NIH supporta Percent of NIH
schools all schools for research support for all schools
Departments 19 18.3 228.8 37.8
Divisions 28 26.9 198.3 32.7
Neither 57 54.8 179.0 29.5
Total 104 100.0 606.1 100.0
a Millions of dollars for year 1971.
required courses in genetics, 70% list electives, and a total of 78% have either
or both. This enterprise is given status and visibility in 19 schools which list depart-
ments of genetics in the AAMC directory, while 28 more list divisions (90). These
data are set out in Table 4 and are contrasted with the number of departments
of dermatology. This is in no sense an invidious comparison, but perhaps suggests
that, although genetics is fairly widely recognized as a valuable point of view, its
importance to clinical medicine has yet to be fully grasped. Indeed, the evidence
is that genetics is regarded as a basic science. Most of the required courses listed
are given in the first or second year of medical school-emphasis on the first, and
as Table 5 shows, the departments, and to a lesser degree the divisions, are to
be found in schools which are strongly research oriented, and do not appear in
schools more concerned with teaching future practitioners than with training in-
vestigators and providing an atmosphere favorable for research (91). It is notable
also that while all schools with a department of genetics give a required course
in genetics, as do three-fourths of those with divisions, only a third of the remaining
schools list a required course. What these data seem to be showing is that at a
time when genetics is becoming less a matter of rare and complicated inborn errors
and more a matter of everyday concern to clinicians and practitioners, there is
some question whether the medical schools are ready to embrace the change.
Everyone would agree that departments and divisions of genetics are ideal places
for research into all aspects of human genetics, including theoretical population
genetics, and as a source of stimulus and teaching. But these institutions may not
be ideal for the research and teaching appropriate for the kind of clinical popula-
tion genetics which seems to be emerging today. A perfect site for these operations
might be the departments of family practice, community medicine, or as some "out
of it" schools still call them, departments of preventive medicine. These institutions
are oriented toward families and to the population, are interested in health as well
308GARROD, GALTON, AND MEDICINE
TABLE 6
AMERICAN MEDICAL SCHOOLS THAT HAVE DEPARTMENTS OR DIVISIONS OF GENETICS TEND NOT To
HAVE DEPARTMENTS OF COMMUNITY MEDICINE, FAMILY PRACTICE, OR PREVENTIVE MEDICINE
Department of community medicine
Has dept. No dept. Total
D)epartments of genetics 9 10 19
Division of genetics 19 9 28
Neither department nor divisioni 50 7 .57
Total 78 26 104
as illness, are accustomed to taking health care to the patient, family, and com-
munity, think epidemiologically, and do just the kind of research which needs to
be done to evaluate and improve screening and counseling. Screening, antenatal
diagnosis, and genetic counseling raise many questions of impact, efficacy, com-
pliance, and even of ethics, which should be studied with the same kind of rigorous
testing of ideas, of experimental design, and of planning that is given to laboratory
research. Geneticists and clinicians, in general, have not worked with the methods
of health education, medical sociology, and epidemiology and need the guidance
of experts. Furthermore, these departments of community and preventive medicine
also have the advantage of ubiquity. Medical programs in the population genetics
vein must be widespread to be successful. That is, to reduce significantly the in-
cidence of mongolism, all obstetricians should know about the effectiveness of ante-
natal diagnosis and most should cooperate. Table 6 reveals that most medical
schools do have departments of community or preventive medicine and that these
do not greatly overlap with those having departments and divisions of genetics.
The table reveals that schools which emphasize genetics tend either to leave pre-
ventive medicine to their schools of public health, which are not necessarily in
close collaboration, or not to bother with it at all, while those which emphasize
family practice, community, and preventive medicine often lack departments or
divisions of genetics. This stresses the major flaw in this plan-these departments
have everything favorable to its success but genetics. This is suggested by a survey
of 18 well-known and widely read texts on these subjects, all published since 1960
(92-109). Only one half had any reference to genetics at all, and most of those
that did treated it in a perfunctory, absent-minded way.
The remedy for this deficiency, I do not know. If screening and antenatal diagno-
sis continue to proliferate and the need for widespread counseling increases, it may
be that teachers of family practice, community medicine, and preventive medicine
will see their responsibilities and will take them up. To this end it should be the
role of medical geneticists to emphasize the effects of gene segregation on all as-
pects of variation among the members of those social groups which are the objects
of study by those who profess community and preventive medicine; namely, the
family and the population.
SUMMARY
It seems almost as if the concern for genes and chromosomes as causes of disease
has paradoxically obscured the evolutionary aspects of genetics, its predictive quali-
ties, its social applications, and its role in describing the sources of variation of
human development and life. Full appreciation by physicians of these qualities
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would be likely to modify the traditional doctor-patient relationship by introducing
a socielal outlook not now commonly expressed.
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